Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-20

Clinical Trial Update: Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses the effects of curcumin supplementation on lipid profiles and inflammatory markers in patients with type 2 diabetes, spanni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin supplement (curcumin)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Non Insulin Dependent Diabetes | Phase 2, Phase 3 | Status: UNKNOWN